Search
Search Results
##search.searchResults.foundPlural##
-
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
770PDF: 485HTML: 6286 -
COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis
631PDF: 375Html: 35 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3201PDF: 1670HTML: 369 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2150PDF: 1093HTML: 15737COVER LETTER: 216 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1689PDF: 1928Suppl. Files: 219HTML: 111 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4315PDF: 2037HTML: 1958 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2125PDF: 134HTML: 40 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1537PDF: 1378HTML: 118 -
EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF PEDIATRIC COVID-19 IN THE TERTIARY CARE SYSTEM IN THAILAND: COMPARATIVE DELTA AND PRE-DELTA ERA Pediatric COVID-19 in Thailand during pre-Delta and Delta era
1172PDF: 642HTML: 291 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3361PDF: 938HTML: 1550Fig.1 CHL-R paper: 246Fig 2 CHL-R paper: 268 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2300PDF: 1675HTML: 617 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1598PDF: 940HTML: 387 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3469PDF: 2047HTML: 7576 -
SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
3485PDF: 794HTML: 1130Cover Letter: 226 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2350PDF: 926HTML: 2018Fig 1 Rossi: 225 -
THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA in TDT
215PDF: 197HTML: 54 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2460PDF: 1251HTML: 3900 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
1029PDF: 611Html: 311Suppl. Files: 197 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
887PDF: 141HTML: 224 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3784PDF: 1741HTML: 2697 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1522PDF: 894HTML: 1113Untitled: 205 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
4167PDF: 1384HTML: 2539 -
FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL
2521HTML: 9430DOCX: 1046Tables Dengue: 240 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1918PDF: 844HTML: 234 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3365PDF: 1083HTML: 2406







